Bentham Science Logo

Track Your Manuscript:


Current Neuropharmacology

Volume 20, 12 Issues, 2022
ISSN: 1875-6190 (Online)
ISSN: 1570-159X (Print)
This journal supports open access

Contents

Current Neuropharmacology , Volume 13 - Number 5




Treatment-resistant Late-life Depression: Challenges and Perspectives

, 13(5): 577 - 591

Christian Knochel, Gilberto Alves, Benedikt Friedrichs, Barbara Schneider, Anna Schmidt-Rechau, Sofia Wenzler, Angelina Schneider, David Prvulovic, Andre F. Carvalho and Viola Oertel-Knochel


DOI: 10.2174/1570159X1305151013200032





Beyond Monoamines-Novel Targets for Treatment-Resistant Depression: A Comprehensive Review

, 13(5): 636 - 655

Joshua D. Rosenblat, Roger S. McIntyre, Gilberto S. Alves, Konstantinos N. Fountoulakis and Andre F. Carvalho


DOI: 10.2174/1570159X13666150630175044



Omega 3 Fatty Acids: Novel Neurotherapeutic Targets for Cognitive Dysfunction in Mood Disorders and Schizophrenia?

, 13(5): 663 - 680

Christian Knochel, Martin Voss, Florian Gruter, Gilberto S. Alves, Silke Matura, Beate Sepanski, Michael Stablein, Sofia Wenzler, David Prvulovic, Andre F. Carvalho and Viola Oertel-Knochel


DOI: 10.2174/1570159X13666150630173047






Editor-in-Chief

Ferdinando Nicoletti
Department of Pharmaceutical Sciences
University Rome"da Sapienza"
Rome
(Italy)
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Neuropharmacology was introduced in 2003 and Dr. Ferdinando Nicoletti is the New Editor-in-Chief of the journal, appointed in 2019.
New eBook



You can view the contents of this eBook [here] or purchase it [here].

Advertisement

Jan-2022-banMechanisms-of-Metabolic-Disorders-(MMD)

Related Journals

Related eBooks

eBooks Catalog